How much funding has deCode Genetics raised?

deCode Genetics has raised $173.0M in total funding, most recently a Venture Round.

When was deCode Genetics founded?

deCode Genetics was founded in 1996.

Where is deCode Genetics headquartered?

deCode Genetics is headquartered in Reykjavik, Iceland.

What industry is deCode Genetics in?

deCode Genetics operates in Biotech.

How many employees does deCode Genetics have?

deCode Genetics has 201-500 employees.

deCode Genetics

Q: Who are deCode Genetics's investors?

deCode Genetics's investors include Amgen, ARCH Venture Partners, Polaris Partners.

Acquired

24front

Reykjavik, Iceland · Founded 1996 · $173.0M raised

Biotech

Headquarters: Reykjavik
Employees: 201–500
Founded: 1996
Business Model: B2B

Website: decode.com
Total Funding: $173.0M
Last Round: $173.0M Venture RoundJul 2000
Rounds: 1

About

deCODE genetics, an Amgen subsidiary headquartered in Reykjavik, Iceland, is a global leader in analyzing the human genome to identify genetic risk factors for common diseases. Using Iceland's unique population genetics resources, deCODE has discovered risk factors for dozens of conditions including cardiovascular disease, cancer, and neurological disorders, advancing drug discovery and development.

Summary

deCode Genetics is a Biotech company based in Reykjavik, Iceland, founded in 1996. It has raised $173.0M in total across 1 round, most recently a $173.0M Venture Round round in Jul 2000. Investors include Amgen, ARCH Venture Partners and Polaris Partners.

LinkedIn X (Twitter)